Barinthus Biotherapeutics (BRNS) Non-cash Items (2020 - 2023)

Barinthus Biotherapeutics has reported Non-cash Items for 4 years, with the latest figure at $4.1 million in Q3 2023.

• For the quarter ending Q3 2023, Non-cash Items fell 52.87% year-over-year to $4.1 million; the trailing twelve-month figure through Sep 2023 stood at $4.1 million (down 52.87% YoY), and the FY2022 full-year result was $7.1 million, down 43.2% from the prior year.
• Non-cash Items for Q3 2023 stood at $4.1 million, down from $6.5 million in the prior quarter.
• The five-year high for Non-cash Items was $19.8 million in Q2 2021, with the low at $3.1 million in Q4 2020.
• Historically, Non-cash Items has averaged $9.9 million across 4 years, with a median of $8.8 million in 2022.
• Annual changes were most pronounced in 2021 — Non-cash Items soared 304.66% — and 2023, when it plunged 52.87%.
• Barinthus Biotherapeutics' Non-cash Items stood at $3.1 million in 2020, then surged by 304.66% to $12.5 million in 2021, then tumbled by 43.2% to $7.1 million in 2022, then slumped by 42.25% to $4.1 million in 2023.
• The last three Non-cash Items figures came in at $4.1 million (Q3 2023), $6.5 million (Q2 2023), and $9.0 million (Q1 2023), per Business Quant data.